ARK Genomic Revolution ETF (ARKG)
BATS: ARKG · Real-Time Price · USD
30.93
-0.97 (-3.04%)
At close: Dec 5, 2025, 4:00 PM EST
30.98
+0.05 (0.16%)
After-hours: Dec 5, 2025, 4:54 PM EST
ARKG Holdings Information
ARKG is an equity ETF with a total of 35 individual holdings. The top holdings are Tempus AI stock at 9.43%, CRISPR Therapeutics AG at 8.63%, Personalis at 6.21%, Guardant Health at 5.68%, and Twist Bioscience at 5.46%.
Total Holdings
25
Top 10 Percentage
57.46%
Asset Class
Equity
ETF Category
Health
Assets
1.23B
PE Ratio
n/a
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | TEM | Tempus AI, Inc. | 9.43% |
| 2 | CRSP | CRISPR Therapeutics AG | 8.63% |
| 3 | PSNL | Personalis, Inc. | 6.21% |
| 4 | GH | Guardant Health, Inc. | 5.68% |
| 5 | TWST | Twist Bioscience Corporation | 5.46% |
| 6 | BEAM | Beam Therapeutics Inc. | 4.86% |
| 7 | NTRA | Natera, Inc. | 4.51% |
| 8 | TXG | 10x Genomics, Inc. | 4.47% |
| 9 | RXRX | Recursion Pharmaceuticals, Inc. | 4.30% |
| 10 | VCYT | Veracyte, Inc. | 3.91% |
| 11 | ILMN | Illumina, Inc. | 3.90% |
| 12 | ADPT | Adaptive Biotechnologies Corporation | 3.47% |
| 13 | ABSI | Absci Corporation | 3.37% |
| 14 | CDNA | CareDx, Inc | 3.10% |
| 15 | IONS | Ionis Pharmaceuticals, Inc. | 3.04% |
| 16 | SDGR | Schrödinger, Inc. | 2.64% |
| 17 | NTLA | Intellia Therapeutics, Inc. | 2.37% |
| 18 | PACB | Pacific Biosciences of California, Inc. | 2.07% |
| 19 | NRIX | Nurix Therapeutics, Inc. | 2.06% |
| 20 | WGS | GeneDx Holdings Corp. | 1.80% |
| 21 | PRME | Prime Medicine, Inc. | 1.44% |
| 22 | BFLY | Butterfly Network, Inc. | 1.43% |
| 23 | ARCT | Arcturus Therapeutics Holdings Inc. | 1.25% |
| 24 | AMGN | Amgen Inc. | 1.15% |
| 25 | ATAI | Atai Beckley N.V. | 1.09% |
As of Dec 5, 2025